Latest Breaking News On - Glaukos corporation - Page 17 : comparemela.com

Ophthalmic Equipment Market Worth $88 5 Billion

/PRNewswire/ Ophthalmic Equipment Market in terms of revenue was estimated to be worth $66.2 billion in 2023 and is poised to reach $88.5 billion by 2029,.

South koreaUnited statesAashish mehraCarl zeiss meditecAsia pacificTopcon corporation japanBausch health companies incMarket developmentClear lab singaporeCoburn technologies incAppasamy associates indiaHoya corporation japanCompany typeNidek co ltdMatronix india corporationGlaukos corporation

Glaukos Co (NYSE:GKOS) CEO Sells $4,953,000 00 in Stock

Glaukos Co. (NYSE:GKOS – Get Free Report) CEO Thomas William Burns sold 60,000 shares of Glaukos stock in a transaction on Monday, January 8th. The shares were sold at an average price of $82.55, for a total transaction of $4,953,000.00. Following the transaction, the chief executive officer now owns 55,835 shares in the company, valued […]

Stifel nicolausThomas william burnsPiper sandlerMorgan stanleyComerica bankNeedham companyJpmorgan chase coHarbor capital advisors incGlaukos corporationManufacturers life insurance companyGlaukos coDeutsche bankWells fargo companyGet free reportWilliam burnsCapital advisors

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced its.

Exchange commissionGlaukos corporationMicro invasive glaucoma surgeryQuarterly reportInvestor section

Glaukos (GKOS) Reports Prelim Q4 Revenue, Affirms FY24 Guidance

Glaukos (GKOS) Reports Prelim Q4 Revenue, Affirms FY24 Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Glaukos corporation

Glaukos Co to Post Q1 2024 Earnings of ($0 58) Per Share, Zacks Research Forecasts (NYSE:GKOS)

Glaukos Co. (NYSE:GKOS – Free Report) – Research analysts at Zacks Research upped their Q1 2024 EPS estimates for shares of Glaukos in a report issued on Wednesday, January 3rd. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings of ($0.58) per share for the quarter, up from their […]

Thomas william burnsAlexr thurmanStifel nicolausVanguard group incZacks researchFred alger managementGlaukos coBrown capital managementNeedham companyJpmorgan chase coGlaukos corporationSecurities exchange commissionMorgan stanleyFree reportGet free reportWilliam burns